MEF2C Gene Mental Retardation Autosomal Dominant Type 20 NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Development Disorders
The MEF2C Gene Mental Retardation Autosomal Dominant Type 20 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced screening method specifically targets the MEF2C (Myocyte Enhancer Factor 2C) gene, which plays a critical role in brain development and cognitive function. Mutations in this gene are directly linked to autosomal dominant mental retardation type 20, a condition characterized by significant intellectual disability and developmental delays.
What Does This Test Measure?
Our NGS-based genetic test provides comprehensive analysis of the MEF2C gene to identify:
- Point mutations and single nucleotide variants
- Small insertions and deletions (indels)
- Copy number variations affecting the MEF2C gene
- Structural rearrangements impacting gene function
- Specific pathogenic variants associated with mental retardation type 20
The test utilizes state-of-the-art Next-Generation Sequencing technology, ensuring high accuracy and comprehensive coverage of the entire MEF2C gene coding region and flanking sequences.
Who Should Consider This Test?
This genetic screening is recommended for individuals presenting with:
- Unexplained intellectual disability or developmental delays
- Family history of autosomal dominant mental retardation
- Neurological symptoms without clear diagnosis
- Children showing significant cognitive impairment
- Individuals with suspected genetic neurological disorders
- Patients with developmental regression or stagnation
Clinical Benefits and Importance
Undergoing the MEF2C genetic test provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out MEF2C-related disorders with precision
- Treatment Guidance: Informs personalized treatment and intervention strategies
- Genetic Counseling: Provides essential information for family planning decisions
- Early Intervention: Enables timely therapeutic interventions for better outcomes
- Family Risk Assessment: Identifies inheritance patterns and recurrence risks
Understanding Your Test Results
Our comprehensive genetic counseling service helps interpret your results:
- Positive Result: Indicates the presence of pathogenic MEF2C mutations, confirming diagnosis of autosomal dominant mental retardation type 20
- Negative Result: Suggests absence of known MEF2C mutations, though other genetic causes may need investigation
- Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact requiring further evaluation
- Carrier Status: Determines inheritance patterns and family member risks
All results are accompanied by detailed explanations and recommendations from our certified genetic counselors.
Test Pricing and Details
| Test Feature | Details |
|---|---|
| Test Name | MEF2C Gene Mental Retardation Autosomal Dominant Type 20 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing services nationwide.
Take the Next Step Toward Genetic Clarity
Don’t let uncertainty about neurological symptoms affect your quality of life. Our MEF2C genetic test provides the answers you need for informed healthcare decisions. Schedule your appointment today and take advantage of our special pricing.
Call or WhatsApp us now at +1(267) 388-9828 to book your MEF2C Gene Mental Retardation Autosomal Dominant Type 20 NGS Genetic DNA Test. Our genetic specialists are ready to assist you with comprehensive testing and counseling services.
